The Serum Apolipoprotein Profile of Patients with Glucose-6-Phosphatase Deficiency
- 1 April 1985
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 19 (4) , 380-384
- https://doi.org/10.1203/00006450-198519040-00013
Abstract
Abnormal lipid transport is 1 of the more severe pathophysiological manifestations of glucose-6-phosphatase deficiency (glycogen storage disease, type I: GSD-I). To characterize further lipoprotein abnormalities in this inborn error of glycogen metabolism, the levels of serum apolipoproteins (Apo) A-I, A-II, B, C-I, C-II, C-III, D and E were determined in 10 male and 12 female patients, 1-37 yr of age. Patients with GSD-I have a unique apolipoprotein profile characterized by normal or slightly decreased levels of ApoA-I and ApoA-II, reduced concentrations of ApoD and significantly increased levels of ApoC-I and ApoC-II (P < 0.01) and ApoB, ApoC-III, and ApoE (P < 0.0001) in comparison with age- and sex-matched normolipidemic controls. However, there was some overlap of values in patients and controls for each of the lipid and apolipoprotein constitutents with the exception of ApoC-III. This finding supported by the results of the logistic regression analysis showed that the concentration of ApoC-III is the best criterion for distinguishing patients with GSD-I from control subjects and the most characteristic feature of the deranged lipid transport system in this deficiency disease. It remains to be clarified, however, whether the ApoC-III concentrations in patients with GSD-I reflect the degree of other metabolic and clinical manifestations of this disease such as hyperlacticacidemia, hyperuricemia and growth retardation.This publication has 15 references indexed in Scilit:
- A comprehensive evaluation of the heparin–manganese precipitation procedure for estimating high density lipoprotein cholesterolPublished by Elsevier ,2021
- Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemiaEuropean Journal of Clinical Investigation, 1980
- Quantitative determination of human apolipoprotein Cc-III by electroimmunoassayBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Serum lipoproteins of patients with glycogen storage diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1980
- Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography.Journal of Lipid Research, 1980
- Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B.Clinical Chemistry, 1978
- Quantitative determination of human apolipoprotein D by electroimmunoassay and radial immunodiffusionBiochimica et Biophysica Acta (BBA) - Protein Structure, 1977
- Determination of human apolipoprotein e by electroimmunoassayBiochimica et Biophysica Acta (BBA) - Protein Structure, 1976
- Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays.Clinical Chemistry, 1976
- THE HYPERLIPEMIAS IN DISORDERS OF CARBOHYDRATE METABOLISM - SERIAL LIPOPROTEIN STUDIES IN DIABETIC ACIDOSIS WITH XANTHOMATOSIS AND IN GLYCOGEN STORAGE DISEASE1955